Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $215
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Mike Cyprys has maintained an Equal-Weight rating on CME Group (NASDAQ:CME) and raised the price target from $211 to $215.
October 11, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on CME Group and raised the price target from $211 to $215.
The news is directly related to CME Group as Morgan Stanley has maintained an Equal-Weight rating on the company and raised the price target. This suggests that the analyst sees potential upside in the stock, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100